A prospective randomized double blind study using intranasal oxytocin versus placebo at the waning of a social stress task (Trier Social Stress Test: TSST) found a decreased dysphoric stress-induced feeling in BPD patients compared to controls and a lower plasma cortisol rate when OXT was administered (Simeon et al., 2011). This evidence concerns the gene OXT and Borderline personality disorder.